IRCT20220115053718N1 IRCT 2022-01-21 Esfahan University of Medical Sciences Effect of TECAR therapy on the improvement of symptoms and function of patients with lateral epicondylitis Evaluation of TECAR therapy on the improvement of symptoms and function of patients with lateral epicondylitis 2022-01-21 anticipated 46 Complete https://irct.ir/trial/61389 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, 46 eligible patients are randomly selected. For this, the letter A is written on 23 sheets, and the letter B is written on 23 sheets, and each of them is placed in an envelope. Each patient is then asked to choose one of the envelopes. Depending on the selected envelope, the patient is assigned to one of two groups, Blinding description: Due to the different nature of the intervention in the two groups, the researcher and the patient are aware of the type of intervention, but the outcome assessor, data collector and statistical analyst will not be aware of the type of intervention. 3 Lateral epicondylitis. Intervention 1: Intervention group: Patients in this group undergo TECAR therapy for 5 sessions, 3 days a week (every other day for 2 weeks). In addition, meloxicam 15 mg is prescribed for two weeks. The use of brace (Cock-up) is also prescribed during treatment. Intervention 2: Control group: For patients in this group, meloxicam 15 mg is prescribed for two weeks. The use of brace (Cock-up) is also prescribed during treatment. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no further information